Status:

COMPLETED

Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow)

Lead Sponsor:

University of Pennsylvania

Conditions:

Brain Tumor, Primary

Brain Tumor, Recurrent

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

Primary malignant and non-malignant brain tumors account for an estimated 21.42 cases per 100,000 for a total count of 343,175 incident tumors based on worldwide population estimates \[1\]. These enti...

Detailed Description

Indocyanine green is a water-soluble tricarbocyanine dye routinely used in clinical settings for measuring cardiac output, hepatic function, liver blood flow and ophthalmic angiography and has been in...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Adult patients 18 years of age and older.
  • Patients presenting with a CNS tumor presumed to be resectable and are at risk for local recurrence on pre-operative assessment
  • Good operative candidate as determined by the treating physician and multidisciplinary team
  • Subject capable of giving informed consent and participating in the process of consent.
  • Exclusion Criteria
  • Pregnant women as determined by urinary or serum beta hCG within 72 hours of surgery
  • Subjects with a history of iodide allergies
  • Vulnerable patient populations
  • a. Patients unable to participate in the consent process (children and neonates).
  • Patients with non-MRI compatible implanted metallic foreign bodies are excluded from this study"
  • Patients who due to severe claustrophobia cannot tolerate MRI scanning"
  • Patients with a known allergy or hypersensitivity to MRI contrast agents including gadolinium .
  • Patients with moderate to end-stage renal (kidney) disease, defined as a glomerular filtration rate (GFR) less than 30 mL/day/1.73m2

Exclusion

    Key Trial Info

    Start Date :

    June 1 2015

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    March 10 2020

    Estimated Enrollment :

    363 Patients enrolled

    Trial Details

    Trial ID

    NCT03262636

    Start Date

    June 1 2015

    End Date

    March 10 2020

    Last Update

    August 14 2020

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.